Form 4: Neurocrine Biosciences Executive Reports Stock Transaction
Insider Transaction (Form 4)
Jude Onyia, Chief Scientific Officer of Neurocrine Biosciences Inc, reported a transaction in 2,409 shares of common stock on August 4, 2026.
Summary
- Bona fide gift: disposed of 2,409 Common Stock on August 4, 2026; holds 20,996 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Jude Onyia — Officer (Chief Scientific Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-04 | Bona fide gift | Common Stock | 2,409 | — | — | 20,996 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-04 | Bona fide gift (2,409 shares) |
Keywords
insider transaction, Form 4, NBIX, NEUROCRINE BIOSCIENCES INC, neutral, Jude Onyia
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.